Literature DB >> 16724675

Cytogenetic findings in untreated patients with essential thrombocythemia.

Anna D Panani1.   

Abstract

Essential thrombocythemia (ET) is a chronic myeloid disorder that is characterized by persistent thrombocytosis, thrombohemorrhagic symptoms and a low risk of transformation to leukemia. Chromosomal abnormalities in ET are very rare and most of the patients studied were either in leukemic transformation or they had received treatment with cytotoxic agents. The number of cases studied at the time of diagnosis is very limited. In the present study, 67 cases with ET, at the time of diagnosis, were cytogenetically studied by a G-banding technique. Among them, only four presented chromosomal abnormalities. In two cases, a del(5)(q13q33) was identified, accompanied by trisomy 20 in one case, while, in the other case, monosomy 17 and a small marker chromosome were additionally found. In each of the remaining two abnormal cases, clonal isolated trisomy 13 or monosomy 14 were found, respectively. Since these chromosomal abnormalities were found at the time of diagnosis, they might be related to the neoplastic process. The documentation of more cases of chromosomal abnormalities in ET at the time of diagnosis may facilitate the identification of candidate genes involved in the neoplastic process.

Entities:  

Mesh:

Year:  2006        PMID: 16724675

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  3 in total

1.  Cytogenetic abnormalities in essential thrombocythemia at presentation and transformation.

Authors:  Matjaz Sever; Hagop Kantarjian; Sherry Pierce; Nitin Jain; Zeev Estrov; Jorge Cortes; Srdan Verstovsek
Journal:  Int J Hematol       Date:  2009-08-29       Impact factor: 2.490

2.  Myeloid neoplasms with isolated del(5q) and JAK2 V617F mutation: a "grey zone" combination of myelodysplastic and myeloproliferative features?

Authors:  Valentina F I Sangiorgio; Julia T Geyer; Elizabeth Margolskee; Mustafa Al-Kawaaz; Susan Mathew; Wayne Tam; Attilio Orazi
Journal:  Haematologica       Date:  2019-09-26       Impact factor: 9.941

Review 3.  Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors.

Authors:  S Cerquozzi; A Tefferi
Journal:  Blood Cancer J       Date:  2015-11-13       Impact factor: 11.037

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.